Associations between apolipoprotein E genotypes and serum levels of glucose, cholesterol, and triglycerides in a cognitively normal aging Han Chinese population

Clinical Interventions in Aging

Volumn 9, Issue , 2014, Pages 1063-1067

  Tao, Qing Qing ^a   Chen, Yan ^b,c   Liu, Zhi Jun ^a   Sun, Yi Min ^a   Yang, Ping ^a   Lu, Shen Ji ^a   Xu, Miao ^a   Dong, Qin Yun ^a   Yang, Jia Jun ^b   Wu, Zhi Ying ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^c Division of Minimally Invasive Gynecology   (China)

Author keywords

Alzheimer's disease; APOE; Cholesterol; Glucose level; Triglycerides

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CHOLESTEROL; GENOMIC DNA; GLUCOSE; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ARTICLE; CHINA; CHINESE; CHOLESTEROL BLOOD LEVEL; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; TRIACYLGLYCEROL BLOOD LEVEL; AGED; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREVALENCE; REFERENCE VALUE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CHOLESTEROL; COGNITION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REFERENCE VALUES; TRIGLYCERIDES;

EID: 84904171711     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S62554     Document Type: Article

References (24)

1. Tanzi RE. The genetics of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(10):a006296.
2. Vance JE. Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases. Dis Model Mech. 2012;5(6):746-755.
3. Zlokovic BV. Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. JAMA Neurol. 2013;70(4):440-444.
4. Martins IJ, Hone E, Foster JK, et al. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiatry. 2006;11(8):721-736.
5. Liu HC, Hong CJ, Wang SJ, et al. ApoE genotype in relation to AD and cholesterol: a study of 2,326 Chinese adults. Neurology. 1999;53(5):962-966.
6. Raygani AV, Rahimi Z, Kharazi H, Tavilani H, Pourmotabbed T. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease. Neurosci Lett. 2006;408(1):68-72.
7. Protas HD, Chen K, Langbaum JB, et al. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol. 2013;70(3):320-325.
8. Dash SK. Cognitive impairment and diabetes. Recent Pat Endocr Metab Immune Drug Discov. 2013;7(2):155-165.
9. Chen Z, Zhong C. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol. 2013;108:21-43.
10. Crichton GE, Elias MF, Buckley JD, Murphy KJ, Bryan J, Frisardi V. Metabolic syndrome, cognitive performance, and dementia. J Alzheimers Dis. 2012;30(Suppl 2):S77-S87.
11. Crane PK, Walker R, Hubbard RA, et al. Glucose levels and risk of dementia. N Engl J Med. 2013;369(6):540-548.
12. Yaffe K, Falvey C, Hamilton N, et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol. 2012;69(9):1170-1175.
13. Kerti L, Witte AV, Winkler A, Grittner U, Rujescu D, Floel A. Higher glucose levels associated with lower memory and reduced hippocampal microstructure. Neurology. 2013;81(20):1746-1752.
14. Burns CM, Chen K, Kaszniak AW, et al. Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions. Neurology. 2013;80(17):1557-1564.
15. Bertolucci PH, Brucki SM, Campacci SR, Juliano Y. [The Mini-Mental State Examination in a general population: impact of educational status]. Arq Neuropsiquiatr. 1994;52(1):1-7. Portuguese.
16. Almeida OP. [Mini Mental State Examination and the diagnosis of dementia in Brazil]. Arq Neuropsiquiatr. 1998;56(3B):605-612. Portuguese.
17. Donohoe GG, Salomaki A, Lehtimaki T, Pulkki K, Kairisto V. Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clin Chem. 1999;45(1):143-146.
18. Sanabria-Diaz G, Martinez-Montes E, Melie-Garcia L; Alzheimer's Disease Neuroimaging Initiative. Glucose metabolism during resting state reveals abnormal brain networks organization in the Alzheimer's disease and mild cognitive impairment. PloS One. 2013;8(7):e68860.
19. Patil SP, Ballard R, Sanchez S, Osborn J, Santangelo D Jr. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition? Med Hypotheses. 2012;78(4):494-496.
20. Ossenkoppele R, van der Flier WM, Zwan MD, et al. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology. 2013;80(4):359-365.
21. de la Monte SM, Wands JR. Alzheimer's disease is type 3 diabetes: evidence reviewed. J Diabetes Sci Technol. 2008;2(6):1101-1113.
22. Lin SK, Kao JT, Tsai SM, et al. Association of apolipoprotein E genotypes with serum lipid profiles in a healthy population of Taiwan. Ann Clin Lab Sci. 2004;34(4):443-448.
23. Katzman R, Zhang MY, Chen PJ, et al. Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia. Neurology. 1997;49(3):779-785.
24. Larson IA, Ordovas JM, DeLuca C, Barnard JR, Feussner G, Schaefer EJ. Association of apolipoprotein (Apo) E genotype with plasma apo E levels. Atherosclerosis. 2000;148(2):327-335.